Francisco J Bermúdez-Silva Selected Research

4-(3-3,4-p-menthadien-(1,8)-yl)olivetol

1/2022	Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
1/2020	The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco J Bermúdez-Silva Research Topics

Disease

9	Obesity 04/2022 - 02/2009
9	Body Weight (Weight, Body) 04/2022 - 02/2009
4	Insulin Resistance 04/2022 - 01/2011
4	Inflammation (Inflammations) 04/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 04/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Glucose Intolerance 01/2021
1	Hyperglycemia 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Prediabetic State (Prediabetes) 01/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Substance-Related Disorders (Drug Abuse) 07/2013
1	Cocaine-Related Disorders (Cocaine Addiction) 07/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Colitis 01/2012
1	Ulcerative Colitis 01/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012
1	Schizophrenia (Dementia Praecox) 07/2009

Drug/Important Bio-Agent (IBA)

7	CannabinoidsIBA 01/2022 - 02/2009
5	EndocannabinoidsIBA 07/2013 - 02/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2009
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2013 - 01/2011
2	CytokinesIBA 01/2022 - 01/2021
2	4-(3-3,4-p-menthadien-(1,8)-yl)olivetolIBA 01/2022 - 01/2020
2	CannabidiolIBA 01/2021 - 01/2020
2	CarbohydratesIBA 01/2013 - 04/2012
2	AM 251 (AM251)IBA 01/2013 - 01/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 01/2013
1	Insulin (Novolin)FDA Link 04/2022
1	Alanine Transaminase (SGPT)IBA 04/2022
1	Peptides (Polypeptides)IBA 04/2022
1	CreatinineIBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2014
1	Cocaine (Cocaine HCl)IBA 07/2013
1	anandamide (arachidonylethanolamide)IBA 07/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 07/2013
1	gamma-Aminobutyric Acid (GABA)IBA 07/2013
1	Glycerol (Glycerine)FDA LinkGeneric 07/2013
1	Glutamic Acid (Glutamate)FDA Link 07/2013
1	HydrolasesIBA 01/2013
1	Phospholipase DIBA 01/2013
1	EnzymesIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Uncoupling Protein 3IBA 01/2013
1	phosphatidylethanolamineIBA 01/2013
1	Leucine (L-Leucine)FDA Link 01/2013
1	LipidsIBA 01/2013
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2013
1	Monoacylglycerol LipasesIBA 01/2013
1	AdiponectinIBA 04/2012
1	1-dodecylpyridoxal (PLD)IBA 01/2012
1	GlucocorticoidsIBA 01/2012
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2012
1	Peroxisome ProliferatorsIBA 01/2012
1	CholesterolIBA 02/2009

Therapy/Procedure

2	Fat-Restricted Diet (Diet, Fat Restricted) 04/2012 - 01/2011
1	Oral Administration 04/2022
1	Self Administration (Administration, Self) 07/2013
1	Aftercare (After-Treatment) 01/2012
1	Therapeutics 01/2012